<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: This study was initiated to clarify the possible association between <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, mediators of microthrombus formation, and <z:mp ids='MP_0004740'>sensorineural hearing loss</z:mp> (SNHL) of unknown origin in a large cohort of patients </plain></SENT>
<SENT sid="1" pm="."><plain>STUDY DESIGN: Prospective study </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The study cohort consists of 168 adult patients (&gt;/=18 yr) referred to the University of Pennsylvania's Division of Neurotology and Balance Center for diagnosis and treatment of <z:hpo ids='HP_0001730'>progressive hearing loss</z:hpo> with or without <z:hpo ids='HP_0002321'>vertigo</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A comprehensive screening panel of blood tests for autoimmune and <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> was applied to <z:hpo ids='HP_0000001'>all</z:hpo> patients, including testing for anticardiolipin antibodies, anti-B2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi>, and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Forty-two patients (25%) had at least one elevated <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> marker </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty patients had two or more positive test results </plain></SENT>
<SENT sid="6" pm="."><plain>Of the 42 patients, 64% (n = 27) met the diagnostic criteria for <z:e sem="disease" ids="C0025281" disease_type="Disease or Syndrome" abbrv="">Meniere disease</z:e>, and the remainder were diagnosed with idiopathic SNHL </plain></SENT>
<SENT sid="7" pm="."><plain>Within this group of patients, 24 patients (57%) had <z:e sem="disease" ids="C0521785" disease_type="Disease or Syndrome" abbrv="">unilateral hearing loss</z:e>, and 18 (44%) had <z:e sem="disease" ids="C0018775" disease_type="Disease or Syndrome" abbrv="">bilateral hearing loss</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: These data support the hypothesis that <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> are involved in the pathogenesis of some forms of inner ear dysfunction, presumably by causing microthrombus formation in the labyrinthine vasculature </plain></SENT>
<SENT sid="9" pm="."><plain>Basic science studies are required to better understand the mechanisms by which <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> mediate inner ear dysfunction </plain></SENT>
<SENT sid="10" pm="."><plain>Clinical studies to evaluate the efficacy of anticoagulation in this group of patients are also required </plain></SENT>
</text></document>